Search results for " TOXIC"

showing 10 items of 3345 documents

The ascidian Styela plicata hemocytes as a potential biomarker of marine pollution: In vitro effects of seawater and organic mercury.

2017

Toxic metals, such as mercury, contribute substantially to anthropogenic pollution in many estuarine environments. Animals living in those environments, particularly invertebrate filter feeders like tunicates, can be used as bioindicators. In an attempt to identify cellular markers for revealing pollution, this study examined in vitro the effects of different concentrations of methyl mercury on Styela plicata hemocytes. The harvested hemocytes from S. plicata that were exposed to the metal had a significant mortality, cellular count and morphometric alterations. These findings provided evidence of MeHg immunotoxic effects on S. plicata, resulting in hemocyte death and morphological changes …

0301 basic medicinePollutionHemocytesAscidianHealth Toxicology and Mutagenesismedia_common.quotation_subjectAscidian; Hemocytes; Mercury; Pollution; SEM; Seawater; Toxic metals; TunicateZoologychemistry.chemical_elementHemocyteToxic metal010501 environmental sciencesTunicate01 natural sciencesMarine pollution03 medical and health scienceschemistry.chemical_compoundAnimalsSeawaterUrochordataMethylmercury0105 earth and related environmental sciencesmedia_commonInvertebratebiologyEcologyImmunotoxinsPublic Health Environmental and Occupational HealthGeneral MedicineMercuryMethylmercury Compoundsbiology.organism_classificationPollutionTunicateMercury (element)030104 developmental biologyStyela plicatachemistrySEMMicroscopy Electron ScanningBioindicatorBiomarkersEcotoxicology and environmental safety
researchProduct

Antipoxvirus Activity Evaluation of Optimized Corroles Based on Development of Autofluorescent ANCHOR Myxoma Virus

2021

International audience; A series of 43 antiviral corrole-based molecules have been tested on myxoma virus (Lausanne-like T1MYXV strain). An autofluorescent MYXV, with an ANCHOR cassette, has been used for the studies. A(2)B-fluorocorroles display various toxicities, from 40 being very toxic (CC50 = 1.7 mu M) to nontoxic 38 (CC50 > 50 mu M), whereas A(3)-fluorocorroles, with one to three fluorine atoms, are not toxic (with the exception of corroles 9, 10, and 22). In vitro, these compounds show a good selectivity index when used alone. Corrole 35 seems to be the most promising compound, which displays a high selectivity index with the lowest IC50. Interestingly, this "Hit" corrole is easy to…

0301 basic medicinePorphyrins[SDV]Life Sciences [q-bio]030106 microbiologyresistant strainMyxoma virusAntiviral Agents03 medical and health scienceschemistry.chemical_compoundmyxoma viruscorroleIn vivoAnimalsCorroleIC50Strain (chemistry)biologybiology.organism_classificationantiviralAcute toxicityIn vitro3. Good healthdsDNA virus030104 developmental biologyInfectious DiseaseschemistryBiochemistrypoxvirusRabbitsSelectivity
researchProduct

Apoptosis of Hepatocytes: Relevance for HIV-Infected Patients under Treatment.

2021

Due to medical advances over the past few decades, human immunodeficiency virus (HIV) infection, once a devastatingly mortal pandemic, has become a manageable chronic condition. However, available antiretroviral treatments (cART) cannot fully restore immune health and, consequently, a number of inflammation-associated and/or immunodeficiency complications have manifested themselves in treated HIV-infected patients. Among these chronic, non-AIDS (acquired immune deficiency syndrome)-related conditions, liver disease is one of the deadliest, proving to be fatal for 15–17% of these individuals. Aside from the presence of liver-related comorbidities, including metabolic disturbances and co-infe…

0301 basic medicineProgrammed cell deathChronic conditionantiretroviral drugs; apoptosis; hepatic cell death; HIV; liver; toxicityInflammationApoptosisHIV InfectionsReviewliverModels Biological03 medical and health sciencesLiver disease0302 clinical medicineImmune systemAntiretroviral Therapy Highly ActivemedicineHumans030212 general & internal medicinelcsh:QH301-705.5antiretroviral drugsImmunodeficiencybusiness.industryapoptosisHIVtoxicityGeneral Medicinemedicine.diseasehepatic cell death030104 developmental biologylcsh:Biology (General)LiverApoptosisImmunologyUnfolded protein responseHepatocytesmedicine.symptombusinessCells
researchProduct

Insights into the Structure of the Vip3Aa Insecticidal Protein by Protease Digestion Analysis

2017

Vip3 proteins are secretable proteins from Bacillus thuringiensis whose mode of action is still poorly understood. In this study, the activation process for Vip3 proteins was closely examined in order to better understand the Vip3Aa protein stability and to shed light on its structure. The Vip3Aa protoxin (of 89 kDa) was treated with trypsin at concentrations from 1:100 to 120:100 (trypsin:Vip3A, w:w). If the action of trypsin was not properly neutralized, the results of SDS-PAGE analysis (as well as those with Agrotis ipsilon midgut juice) equivocally indicated that the protoxin could be completely processed. However, when the proteolytic reaction was efficiently stopped, it was revealed t…

0301 basic medicineProteasesHealth Toxicology and MutagenesisSize-exclusion chromatographyBeta sheetBacillus thuringiensislcsh:MedicineBiologyToxicologyCleavage (embryo)ArticleProtein Structure Secondary03 medical and health sciencestrypsin inhibitorsBacterial ProteinsSDS-PAGE artefactprotease stabilitymedicinebacterial secreted proteinsAnimalsTrypsinMode of actionProtein secondary structureVip proteinsIntestinal Secretionslcsh:Rtoxin activationVip proteins; bacterial secreted proteins; toxin activation; proteolytic activation; trypsin inhibitors; <i>Bacillus thuringiensis</i>; SDS-PAGE artefact; protease stabilityTrypsinMolecular biologyLepidoptera030104 developmental biologyBiochemistryproteolytic activationLarvaProteolysisPeptidesAlpha helixmedicine.drugToxins
researchProduct

MycoKey Round Table Discussions of Future Directions in Research on Chemical Detection Methods, Genetics and Biodiversity of Mycotoxins

2018

MycoKey, an EU-funded Horizon 2020 project, includes a series of “Roundtable Discussions” to gather information on trending research areas in the field of mycotoxicology. This paper includes summaries of the Roundtable Discussions on Chemical Detection and Monitoring of mycotoxins and on the role of genetics and biodiversity in mycotoxin production. Discussions were managed by using the nominal group discussion technique, which generates numerous ideas and provides a ranking for those identified as the most important. Four questions were posed for each research area, as well as two questions that were common to both discussions. Test kits, usually antibody based, were one major focus of the…

0301 basic medicineProteomicsSettore CHIM/01 - CHIMICA ANALITICAComputer scienceHealth Toxicology and MutagenesisBiodiversitylcsh:Medicinebiological controlmicrobiomeToxicology//purl.org/becyt/ford/1 [https]transcriptomicscommunication with non-scientistsA better understanding of metabolomics from the cellular to the ecosystem level is needed to inform and control mycotoxin production control and remediation. Antibody-based diagnostics have become an acceptable standard in many practical applications but sophisticated multi-mycotoxin detection protocols are the future for many official regulatory controls especially as the number of toxins that are regulated increases and need more standardization and cross-laboratory validation.antibodies2. Zero hungerGeneticsbiologyNominal groupBiodiversitymetabolomicsGeneral partnershipBiological controlAntibodiesBiological controlCommunication with non-scientists Metabolomics Microbiome Multi-mycotoxin detection protocols Nominal group discussion technique ProteomicsTranscriptomicsmulti-mycotoxin detection protocolsSettore AGR/12 - PATOLOGIA VEGETALECommunication with non-scientistsEnvironmental MonitoringNominal group discussion techniqueOpinionAntibodies03 medical and health sciencesMycotoxicologyBiointeractions and Plant HealthproteomicsFood supplyAnimalsHumansMetabolomicsnominal group discussion technique//purl.org/becyt/ford/1.6 [https]Transcriptomicsbusiness.industryResearchlcsh:RUsabilityMycotoxinsbiology.organism_classification030104 developmental biologyMulti-mycotoxin detection protocolsRound tableRankingMicrobiomeEPSbusinesscommunication with non-scientistToxins
researchProduct

Modelos animales de adicción a las drogas

2017

El desarrollo de modelos animales de refuerzo y adicción a las drogas es imprescindible para el avance en el conocimiento de las bases biológicas de este trastorno y la identificación de nuevas dianas terapéuticas. En función del componente del refuerzo que deseemos estudiar podemos servirnos de un tipo de modelos animales u otros. Podemos utilizar modelos de refuerzo basados en el efecto hedónico primario que produce el consumo de la sustancia adictiva, como los modelos de autoadministración (AA) y autoestimulación eléctrica intracraneal (AEIC), o modelos basados en el componente relacionado con el aprendizaje asociativo y la capacidad cognitiva de realizar predicciones sobre la obtención …

0301 basic medicinePunishment (psychology)media_common.quotation_subjectMedicine (miscellaneous)03 medical and health sciencesTratamiento médicoLucha contra la toxicomanía0302 clinical medicinemedicineReinforcementmedia_commonToxicomaníaComportamientoAddictionConductaCognitionExtinction (psychology)medicine.diseaseConditioned place preferenceAssociative learningPsychiatry and Mental health030104 developmental biologyPsychologyAddictive behaviorSocial psychology030217 neurology & neurosurgery
researchProduct

Innovative Strategies to Develop Chemical Categories Using a Combination of Structural and Toxicological Properties.

2016

Interest is increasing in the development of non-animal methods for toxicological evaluations. These methods are however, particularly challenging for complex toxicological endpoints such as repeated dose toxicity. European Legislation, e.g., the European Union's Cosmetic Directive and REACH, demands the use of alternative methods. Frameworks, such as the Read-across Assessment Framework or the Adverse Outcome Pathway Knowledge Base, support the development of these methods. The aim of the project presented in this publication was to develop substance categories for a read-across with complex endpoints of toxicity based on existing databases. The basic conceptual approach was to combine str…

0301 basic medicineQuantitative structure–activity relationshipread acrossPredictive Clustering Tree (PCT) methodComputer science610010501 environmental sciencescomputer.software_genre600 Technik Medizin angewandte Wissenschaften::610 Medizin und Gesundheit01 natural sciences03 medical and health sciencesPharmacology (medical)Cluster analysis0105 earth and related environmental sciencesOriginal ResearchAlternative methodsPharmacologytoxicological and structural similaritybusiness.industryQSARlcsh:RM1-950non-animal methods; QSAR; readacross; Predictive Clustering Tree (PCT) method; toxicological and structural similarityIdentification (information)Tree (data structure)030104 developmental biologyConceptual approachlcsh:Therapeutics. PharmacologyKnowledge basenon-animal methodsData miningWeb servicebusinesscomputerFrontiers in pharmacology
researchProduct

New Insights into the Genome Organization of Yeast Killer Viruses Based on “Atypical” Killer Strains Characterized by High-Throughput Sequencing

2017

Viral M-dsRNAs encoding yeast killer toxins share similar genomic organization, but no overall sequence identity. The dsRNA full-length sequences of several known M-viruses either have yet to be completed, or they were shorter than estimated by agarose gel electrophoresis. High-throughput sequencing was used to analyze some M-dsRNAs previously sequenced by traditional techniques, and new dsRNAs from atypical killer strains of Saccharomyces cerevisiae and Torulaspora delbrueckii. All dsRNAs expected to be present in a given yeast strain were reliably detected and sequenced, and the previously-known sequences were confirmed. The few discrepancies between viral variants were mostly located aro…

0301 basic medicineRNA recombinationGenotypeHealth Toxicology and Mutagenesis030106 microbiologySaccharomyces cerevisiaelcsh:MedicineTorulaspora delbrueckiidsRNAGenome ViralSaccharomyces cerevisiaeToxicologyGenomeDNA sequencingArticle<i>Saccharomyces cerevisiae</i>; <i>Torulaspora delbrueckii</i>; killer; virus genome; dsRNA; sequencing; HTS; RNA recombination; phylogenetic originphylogenetic origin03 medical and health sciencesTorulaspora delbrueckiiGenomic organizationGeneticsbiologyPhylogenetic treelcsh:RHigh-Throughput Nucleotide SequencingTorulasporasequencingbiology.organism_classificationYeastTorulasporaKiller Factors Yeast030104 developmental biologyPhenotypevirus genomeVirusesRNA ViralHTSkillerToxins
researchProduct

Molecular strategies to increase yeast iron accumulation and resistance.

2018

All eukaryotic organisms rely on iron as an essential micronutrient for life because it participates as a redox-active cofactor in multiple biological processes. However, excess iron can generate reactive oxygen species that damage cellular macromolecules. The low solubility of ferric iron at physiological conditions increases the prevalence of iron deficiency anemia. A common strategy to treat iron deficiency consists of dietary iron supplementation. The baker’s yeast Saccharomyces cerevisiae is used as a model eukaryotic organism, but also as a feed supplement. In response to iron deficiency, the yeast Aft1 transcription factor activates cellular iron acquisition. However, when constituti…

0301 basic medicineSaccharomyces cerevisiae ProteinsTranscription GeneticIronSaccharomyces cerevisiaeBiophysicsSaccharomyces cerevisiaeBiochemistryCofactorBiomaterials03 medical and health sciencesFet3Gene Expression Regulation FungalCth2medicineBaker’s yeastYpk1Transcription factorAlleleschemistry.chemical_classificationReactive oxygen speciesbiologyKinaseIron deficiencyRespirationMetals and AlloysIron deficiencybiology.organism_classificationmedicine.diseaseYeastCell biologyIron toxicity030104 developmental biologychemistryIron-deficiency anemiaChemistry (miscellaneous)biology.proteinAft1Metallomics : integrated biometal science
researchProduct

Developmental effects of the protein kinase inhibitor kenpaullone on the sea urchin embryo

2017

The selection and validation of bioactive compounds require multiple approaches, including in-depth analyses of their biological activity in a whole-animal context. We exploited the sea urchin embryo in a rapid, medium-scale range screening to test the effects of the small synthetic kinase inhibitor kenpaullone. We show that sea urchin embryos specifically respond to this molecule depending on both dose and timing of administration. Phenotypic effects of kenpaullone are not immediately visible, since this molecule affects neither the fertilization nor the spatial arrangement of blastomeres at early developmental stages. Nevertheless, kenpaullone exposure from the beginning of embryogenesis …

0301 basic medicineSea urchinEmbryo NonmammalianIndolesPhysiologymedicine.drug_classHealth Toxicology and MutagenesisMesenchymeSettore BIO/11 - Biologia MolecolareContext (language use)ToxicologyBiochemistry03 medical and health sciencesbiology.animalBotanymedicineAnimalsEpithelial–mesenchymal transitionProtein Kinase InhibitorsSea urchinKinase inhibitorMolecular StructurebiologyEmbryogenesisGene Expression Regulation DevelopmentalCell BiologyGeneral MedicineBlastomereBenzazepinesProtein kinase inhibitorEmbryonic stem cellKenpaulloneCell biology030104 developmental biologymedicine.anatomical_structureEmbryonic developmentembryonic structuresParacentrotusGene expressionComparative Biochemistry and Physiology Part C: Toxicology &amp; Pharmacology
researchProduct